Garbers, Christoph
Heink, Sylvia
Korn, Thomas
Rose-John, Stefan
Article History
First Online: 4 May 2018
Competing interests
: S.R.-J. has acted as a consultant and speaker for AbbVie, Chugai, Genentech Roche, Pfizer and Sanofi. He also declares that he is an inventor on patents owned by CONARIS Research Institute, which develops the sgp130Fc protein olamkicept together with the company I-Mab. S.R.-J. has stock ownership in CONARIS. All other authors declare no competing interests.